Altius Institute for Biomedical Sciences is an independent, nonprofit research organization created to pursue discovery at the leading edge of modern biomedicine.

Enabled by visionary founding funding from GlaxoSmithKline, Altius is creating a new paradigm to catalyze ground-breaking biological innovation, integrate molecular and computational science and engineering, and empower fundamental technology development to radically accelerate the leap from basic to medical breakthroughs.